Pembrolizumab (pembro) as first-line therapy for...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Pembrolizumab (pembro) as first-line therapy for advanced/unresectable or metastatic urothelial cancer: Preliminary results from the phase 2 KEYNOTE-052 study

Balar, A., Bellmunt, J., O'Donnell, P.H., Castellano, D., Grivas, P., Vuky, J., Powles, T., Plimack, E.R., Hahn, N.M., de Wit, R., Pang, L., Savage, M.J., Perini, R., Keefe, S., Bajorin, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw435.25
Date:
October, 2016
File:
PDF, 46 KB
english, 2016
Conversion to is in progress
Conversion to is failed